Image: motorolka, via Shutterstock
Medicines and Healthcare Products Regulatory Agency expects AI to improve its efficiency
The UK’s Medicines and Healthcare Products Regulatory Agency has released a strategic approach to artificial intelligence that should allow it to focus on innovation.
AI should mean the regulator can improve the efficiency of its service, giving it the freedom to focus on other priorities, such as enabling innovation, it said.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.